PortfoliosLab logoPortfoliosLab logo
TYRA vs. ALMS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TYRA vs. ALMS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tyra Biosciences, Inc. (TYRA) and Alumis Inc (ALMS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TYRA achieves a 14.34% return, which is significantly lower than ALMS's 151.13% return.


TYRA

1D
-0.27%
1M
-7.42%
YTD
14.34%
6M
16.38%
1Y
209.58%
3Y*
19.74%
5Y*
10Y*

ALMS

1D
-0.37%
1M
11.31%
YTD
151.13%
6M
114.06%
1Y
775.36%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TYRA vs. ALMS - Yearly Performance Comparison


2026 (YTD)20252024
TYRA
Tyra Biosciences, Inc.
14.34%89.14%-10.03%
ALMS
Alumis Inc
151.13%24.17%-41.78%

Correlation

The correlation between TYRA and ALMS is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Jun 28, 2024

0.22

The correlation between TYRA and ALMS shifts across timeframes, from 0.22 (all time) to 0.33 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TYRA:

$1.86B

ALMS:

$3.06B

EPS

TYRA:

-$2.18

ALMS:

-$2.31

PB Ratio

TYRA:

4.79

ALMS:

5.41

Total Revenue (TTM)

TYRA:

$0.00

ALMS:

$8.40M

Gross Profit (TTM)

TYRA:

-$132.00K

ALMS:

$5.79M

EBITDA (TTM)

TYRA:

-$129.69M

ALMS:

-$411.89M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TYRA vs. ALMS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TYRA
TYRA Risk / Return Rank: 9595
Overall Rank
TYRA Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
TYRA Sortino Ratio Rank: 9595
Sortino Ratio Rank
TYRA Omega Ratio Rank: 9393
Omega Ratio Rank
TYRA Calmar Ratio Rank: 9494
Calmar Ratio Rank
TYRA Martin Ratio Rank: 9696
Martin Ratio Rank

ALMS
ALMS Risk / Return Rank: 9999
Overall Rank
ALMS Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
ALMS Sortino Ratio Rank: 9999
Sortino Ratio Rank
ALMS Omega Ratio Rank: 9898
Omega Ratio Rank
ALMS Calmar Ratio Rank: 9999
Calmar Ratio Rank
ALMS Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TYRA vs. ALMS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tyra Biosciences, Inc. (TYRA) and Alumis Inc (ALMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TYRAALMSDifference
Sharpe ratioReturn per unit of total volatility

-2.96

Sortino ratioReturn per unit of downside risk

-2.45

Omega ratioGain probability vs. loss probability

1.46

1.83

-0.37

Calmar ratioReturn relative to maximum drawdown

5.93

21.36

-15.43

Martin ratioReturn relative to average drawdown

21.99

55.78

-33.79

TYRA vs. ALMS - Sharpe Ratio Comparison

The current TYRA Sharpe Ratio is 3.47, which is lower than the ALMS Sharpe Ratio of 6.42. The chart below compares the historical Sharpe Ratios of TYRA and ALMS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TYRA vs. ALMS - Drawdown Comparison

The maximum TYRA drawdown since its inception was -83.22%, roughly equal to the maximum ALMS drawdown of -79.26%. Use the drawdown chart below to compare losses from any high point for TYRA and ALMS.


Loading charts...

Drawdown Indicators


TYRAALMSDifference

Max Drawdown

Largest peak-to-trough decline

-83.22%

-79.26%

-3.96%

Max Drawdown (1Y)

Largest decline over 1 year

-35.82%

-36.66%

+0.84%

Max Drawdown (3Y)

Largest decline over 3 years

-75.32%

Current Drawdown

Current decline from peak

-24.11%

-18.25%

-5.86%

Average Drawdown

Average peak-to-trough decline

-51.07%

-38.42%

-12.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.62%

14.01%

-4.39%

Volatility

TYRA vs. ALMS - Volatility Comparison

The current volatility for Tyra Biosciences, Inc. (TYRA) is 17.96%, while Alumis Inc (ALMS) has a volatility of 21.24%. This indicates that TYRA experiences smaller price fluctuations and is considered to be less risky than ALMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TYRAALMSDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.96%

21.24%

-3.28%

Volatility (6M)

Calculated over the trailing 6-month period

39.10%

85.49%

-46.39%

Volatility (1Y)

Calculated over the trailing 1-year period

61.46%

121.95%

-60.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

81.80%

116.10%

-34.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.80%

116.10%

-34.30%

Dividends

TYRA vs. ALMS - Dividend Comparison

Neither TYRA nor ALMS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TYRA vs. ALMS - Financials Comparison

This section allows you to compare key financial metrics between Tyra Biosciences, Inc. and Alumis Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M202220232024202520260
1.74M
(TYRA) Total Revenue
(ALMS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TYRA and ALMS have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ALMS has higher volatility (21.24%) compared to TYRA (17.96%). In terms of maximum drawdown, TYRA dropped -83.22% vs ALMS's -79.26%.

ALMS currently has the higher Sharpe Ratio (6.42 vs 3.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TYRA and ALMS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer